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Aims: Physical activity (PA) has many benefits in type 1 diabetes mellitus (type 1 DM).
However, PA levels in people with type 1 DM have not previously been measured
accurately. We aimed to compare objectively measured PA in adults recently diagnosed
with type 1 DM and healthy adults.
Methods: Accelerometer data from 65 healthy adults [mean (SD) age 31 (13), 29%
men] were compared with data from 50 people with type 1 DM [mean (SD) age 33 (10),
64% men], time since diagnosis <3months, HbA1c 76 ± 25 mmol/mol) in the EXTOD
(Exercise for Type 1 Diabetes) pilot study. Briefly, EXTOD investigated the feasibility of
recruiting recently diagnosed adults with type 1 DM into a yearlong exercise intervention.
Multiple-regression models were used to investigate the association between diabetes
status and activity outcomes.
Results: Adults recently diagnosed with type 1 DM spent on average a quarter less
time in moderate-to-vigorous-physical-activity (MVPA) per day than healthy adults [after
adjusting for confounders, predicted values: type 1 DM adults: [mean (SD)] 37.4mins/day
(9.1) Healthy adults: 52.9 mins/day (11.0)]. No difference in MVPA between the groups
was seen at the weekend, but adults with type 1 DM spent more time in light physical
activity (LPA), and less time in sedentary behavior. Time spent in sedentary or LPA during
weekdays did not differ between groups.
Summary: Adults recently diagnosedwith type 1 DMdo lessMVPA. Health care workers
should encourage these people to engage in more PA. Further studies are needed to
assess PA in people with type 1 DM of longer duration.
Keywords: type 1 diabetes, physical activity, sedentary behaviors, newly diagnosed, moderate-to-vigorous-
physical-activity
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KEY MESSAGES
• This is the first study to compare objectivelymeasured physical
activity in adults newly diagnosed with Type 1 diabetes
mellitus (type 1 DM) with people without type 1 DM.
• Adults with newly diagnosed type 1 DM spent over a quarter
less time in moderate-to-vigorous-physical-activity (MVPA)
than adults without type 1 DM.
• Clinicians should assess activity levels of adults with newly
diagnosed type 1 DM and encourage those who are not
reaching guideline targets to do more.
INTRODUCTION
Regular physical activity (PA) plays a key role in the management
of type 1 diabetes mellitus (type 1 DM) (1). It improves insulin
sensitivity and well-being, reduces cardiovascular risk factors
such as blood pressure and lipids and may help to preserve beta
cell function (2). As a result, guidelines recommend that adults
with type 1 DM undertake at least 150min per week of moderate
to vigorous aerobic exercise, spread out over at least 3 days, with
no more than two consecutive days between bouts of aerobic
activity (3, 4).
Most studies investigating physical activity (PA) levels in
adults with type 1 DM have been based on self-reported data
rather than objective data. A retrospective analysis of the
Diabetes and Complications Trial found 19% of participants
(271/1,441) were not achieving recommended PA levels (5). In
the EURODIAB prospective cohort study of 2,185 people with
type 1 DM from 16 European countries, 786 (36%) people were
doing no or only mild PA (6). Similarly, 23% of people with type
1 DM were classed as sedentary and a further 21% were doing
less than one session of exercise per week in the Finnish Diabetic
Nephropathy Study (7). Only one study has objectively measured
PA in adults with type 1 DM. This Canadian study found that
only 43% of women and 55% of men with type 1 DM were active
(8). No difference was found in activity levels between adults with
or without type 1 DM.
In people with established type 1 DM many of the barriers,
motivators and facilitators to PA are similar to the general public,
such as lack of time, work pressures and bad weather (9–11).
They do however require education about the effect of PA on
diabetes control to help prevent low and high blood glucose
around PA something they struggle to manage and worry about.
A qualitative study from our group suggests that newly diagnosed
adults with type 1 DM reduce their levels of PA around the time
of diagnosis (12). They also face additional barriers to PA such as
feeling overwhelmed by their diagnosis and receiving conflicting
advice by healthcare professionals to stop exercising.
No studies have objectively measured the PA levels or patterns
of people recently diagnosed with type 1 DM, a time when
exercise habits may be greatly influenced. This study aimed to
compare objectively measured PA levels in recently diagnosed
adults with type 1 DM to healthy adults.
Abbreviations: Type 1 DM, type 1 diabetes mellitus; PA, Physical activity; LPA,
Light physical activity; MVPA, moderate-to-vigorous-physical-activity.
METHODS
This is an observational cross-sectional study comparing
objectively measured PA data of adults newly diagnosed with
type 1 DM with that of healthy adults. The EXTOD study was
approved by the Birmingham East, North and Solihull Research
Ethics Committee (0/H1206/4), UK, and the study to measure
activity in healthy adults was approved by the Centre for Exercise,
Nutrition and Health Science Ethics Committee, University of
Bristol (EAN 001-15) and was part of RIBM MRes project. All
participants provided written informed consent in accordance
with the Declaration of Helsinki.
Recruitment and Procedures
Objectively measured PA in adults with type 1 DM came from
participants in the Exercise in type 1 diabetes (EXTOD) study (2).
This was a pilot RCT that aimed to assess uptake, intervention
adherence, dropout rates and rate of uptake in a usual care group
and exercise intervention group over 12-months. This study has
been described in detail elsewhere (2, 13). In brief, people aged
between 16 and 60 years, clinically diagnosed with type 1 DM
in the previous 3-months and self-administering their insulin
as part of a multiple dose injection regime, and from 19 UK
hospital sites were invited to participate. Amember of the clinical
team (doctor/diabetes nurse/dietician) at each site approached
people newly diagnosed with type 1 DM and obtained written
informed consent. Objectively measured PA of participants in
this study was measured at baseline, 3, 6, 9 and 12 months. For
the present study, the data from the baseline visit were used. Five
hundred and eight adults with type 1 DM were invited to take
part. Of these 15 took part in the qualitative study and 58 were
randomized into the main EXTOD Study (13).
Healthy adults were recruited from the University of Bristol
and Taunton and Somerset NHS trust duringMarch-June 2016. A
global e-mail was sent out to all members of these two institutions
explaining briefly about the study. In addition, flyers were put out
in public areas. Participants had to be between 18 and 65 years old
and on no medication. Upon request from potential participants,
they were sent the participant information sheet, and if interested
they were invited to attend an appointment at either the Centre
for Exercise, Nutrition and Health Sciences at the University of
Bristol or the Diabetes research unit at Taunton and Somerset
NHS trust.
Procedures
Following informed consent, participants completed a
questionnaire to confirm their health status, smoking status,
and alcohol consumption. Weight and height were measured
using standard procedures. BMI was calculated as weight (kg)
divided by height (m) squared. Participants were provided with
an accelerometer and instructions were given on how to wear
the accelerometer for the next 7 days. Participants returned the
accelerometer 1 week later either by appointment or by post.
Brief feedback was given to the participants on their levels of
activity over the 7 days they wore the accelerometer; a graphical
interpretation of their physical activity over the 7 days was
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delivered via email after they had returned the accelerometer and
the data had been downloaded.
Accelerometry
Participants wore the accelerometer (Actigraph Model GT1M or
GT3X+; Actigraph LLC, Pensacola, FL, USA) on a belt around
the waist during waking hours, apart from swimming or bathing,
for 7 days. The accelerometers were set to record data at 30Hz
and data were summarized for every minute. Accelerometer
data were downloaded using Actilife software (version 6.11.9,
Actigraph LLC) and processed to generate outcome variables
using KineSoft (version 3.3.62; KineSoft, Saskatoon, SK, Canada).
Non-wear time was defined as a period of 60min or longer
with continuous zero values, with a spike tolerance of 2min.
Thresholds of ≥1,952 counts per minute (cpm) and <100 cpm
were used to derive MVPA and sedentary time respectively (14),
with light activity defined as 100–1,951 cpm. For a day to be
considered valid, a minimum of 480min (8 h) of wear time was
required. For a participant’s data to be included in the analysis a
minimum of 3 valid days were required.
Outcome measures were time spent in sedentary behavior
(minutes per day), time spent in LPA (minutes per day), and
time spent in MVPA (minutes per day). Each of these variables
were then summarized by weekday, weekend and all week to
investigate the pattern of PA throughout the week. The number of
bouts of MVPA ≥10min was also used as a comparison between
groups. We used bouts of over 10min as guidelines suggest that
the bouts of exercise that count toward the 150min a week of
moderate or intense activity should be of 10 or more minutes
[3.4].
Analyses
Means/standard deviations and percentages were used to
describe the characteristics of the participants. Differences
between means of the two groups were tested by two-sample t-
tests (normal data), Mann-Whitney U-tests (non-normal data),
and Chi-squared tests (categorical data).
Multiple linear regression was used to assess the association
between diabetes status and activity intensity (minutes of
sedentary activity, light activity and MVPA). Model A was
adjusted for sex, age, wear time, andmodel B was further adjusted
lifestyle factors (BMI, smoking status, and alcohol consumption).
To investigate the difference in the total number of bouts
accumulated by both groups, logistic regression was used.
Adjustment for confounders (model A and B) was made by
creating a binary outcome (equal to or more than the median
number of bouts vs. less than the median number of bouts)
and fitting multiple logistic regression models. Due to not every
participant wearing their accelerometer for 7 days, a sensitivity
analysis was performed, which restricted the analysis to only
those with 7 valid days of accelerometry.
It had not been appropriate to perform a power calculation for
the original study (EXTOD), as it was a pilot. However, a post-
hoc power calculation showed that with an alpha level of 0.05, a
minimum sample size of n = 50 in each arm, means of 52 and
37 min/standard deviations of 21 and 28min of MVPA/day for
healthy adults and adults with type 1 DM respectively, this study
had 85% power to detect differences between the groups.
All analyses were performed using Stata v15 (Stata Statistical
Software: Release 15. StataCorp LLC, College Station, TX).
RESULTS
Fifty-nine participants with type 1 DM had their activity
measured at baseline in the EXTOD study and 79 healthy adults
were recruited to the study. After excluding participants with
invalid accelerometry, there were 50 participants with type 1 DM
(85%) and 65 healthy adults (82%) left for analysis. Demographic
information for those included in analysis is shown in Table 1.
The participants with type 1 DM had a higher percentage of
males, higher BMI and a slightly higher amount of accelerometer
wear time than the healthy adults but were otherwise similar.
Those excluded from analysis were similar to those included in
terms of ethnicity, sex, age, smoking status, HbA1c, and duration
of diagnosis of type 1 DM, but had lower alcohol consumption
and BMI (Supplementary Table 1).
Associations Between Diabetes Status and
Activity Intensity
Table 2 shows the multiple linear regression models for time
spent in sedentary behaviors, LPA, and MVPA in minutes per
day.
For time spent in sedentary behaviors and LPA, there was no
evidence of a difference on weekdays and over the whole week,
but there was evidence for the adults with type 1 DM spending
more time in LPA and less time in sedentary behaviors at the
weekend.
For MVPA, statistical evidence was found for a difference on
weekdays and across the whole week, but not on weekends. On
average the type 1 DM group spent 10.9min less in MVPA per
day than the healthy adults after adjustment for confounders
[(95% CI-22.2, 0.4) p = 0.06], over a quarter less time in MVPA
[Predicted values [Mean (SD)] type 1 DM adults: 37.4 mins/day
(9.1) Healthy adults: 52.9 mins/day (11.0)].
Associations Between Diabetes Status and
Bouts of MVPA
We investigated the difference in number of bouts of MVPA
≥10min further by logistic regression, using the binary variable
based on the median number of bouts as the outcome. No
statistical evidence was found for a difference in numbers of bouts
between the groups for either models (Supplementary Table 2).
DISCUSSION
We have shown for the first time that adults recently diagnosed
with type 1 DM spent over a quarter less time doing MVPA over
the week than healthy adults. This difference seemed to be driven
by the weekdays rather than weekend. There was also evidence
that people with type 1 DM spent more time in LPA and less
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TABLE 1 | Characteristics of adults with Type 1 diabetes and healthy adults.
Type 1 diabetes (n = 50) Healthy adults (n = 65) p-value
Sex (men) (%) 64% 29% <0.001
Age (years) 33 (10) 31 (13) 0.6
Ethnicity (% white-british) 85% 85% 0.7
Ex-smoker 20%a 20%b 0.3
Current smoker 18%a 18%b
Never smoked 62%a 62%b
Alcohol consumption (units) [Median (IQR)] 3 (10)a 6 (7)b 0.09
BMI (Kg/m2) 24.9 (3.9) 23.4 (3.7) 0.006
HbA1c (mmol/mol) [DCCT (%)] 76.3 (24.6) (9.1%) – –
Duration of diagnosis of T1D (days) 62 (23) – –
DAYS OF ACCELEROMETER WEAR (DAYS)
Weekday 4.4 (0.8) 4.1 (1.1) 0.07
Weekend 1.6 (0.7) 1.7 (0.5) 0.01
All week 6.0 (1.0) 5.8 (1.5) 0.01
Mean (SD) unless otherwise stated. an = 49 for Diabetes. bn = 51 for the healthy adults.
TABLE 2 | Multiple linear regression investigating the associations between diabetes status and activity intensity.
Model A Model B
Diabetes vs. no diabetes Regression coefficient (95%CI) p-value Regression coefficient (95%CI) p-value
SEDENTARY
Weekday 20.2 (−17.6, 58.0) 0.3 18.0 (−24.6, 60.5) 0.4
Weekend −19.3 (−56.7, 18.1) 0.3 −40.6 (−82.1, 0.9) 0.06
All week 9.9 (−23.4, 43.2) 0.6 3.5 (−34.3, 41.4) 0.9
LIGHT
Weekday −3.8 (−39.1, 31.5) 0.8 −3.7 (−44.7, 37.3) 0.9
Weekend 35.2 (3.3, 67.0) 0.03 48.3 (12.5, 84.0) 0.009
All week 5.1 (−25.4, 35.6) 0.7 7.2 (−27.8, 42.2) 0.7
MVPA
Weekday −16.7 (−27.5, −6.0) 0.003 −13.5 (−25.5, −1.5) 0.03
Weekend −15.8 (−31.6, 0.07) 0.05 −7.5 (−25.4, 10.4) 0.4
All week −15.2 (−25.2, −5.1) 0.003 −10.9 (−22.2, 0.4) 0.06
All week and weekday sedentary time, light physical activity (LPA) and moderate-to-vigorous-physical-activity (MVPA): Model A n = 115 Model B n = 99. Weekend sedentary, light and
MVPA: Model A n = 107 and Model B n = 91. Model A adjusts for sex, age, and wear time. Model B adjusts for sex, age, wear time, BMI, smoking status, alcohol consumption.
time being sedentary than healthy adults at the weekend, but no
differences in these behaviors was seen on weekdays.
We could only find two studies that have compared objectivity
measured physical activity of people with type 1 DM with
healthy adults. In the first study Brazeau and colleagues using
a motion sensor (SenseWear Pro 3 Armband) measured the
activity of 75 Canadian adults with established type 1 DM and
75 Canadian adults without type 1 DM (8). They found that
although the PA levels of the adults with type 1 DM were
low, only 43% of women and 55% of men being classed as
being active, they were not different from those seen in adults
without type 1 DM. The difference between our finding and
the findings of this study could be due to the fact that our
participants were adults with newly diagnosed diabetes whereas
in the Brazeau et al. study the participants had had type 1 DM
on average for 23 years. In a qualitative study that our group
conducted of newly diagnosed people with type 1DMaround half
reported a reduction in activity levels around diagnosis (12). In
addition, some participants reported being advised by healthcare
practitioners not to exercise. Finally, adults newly diagnosed with
type 1DMplaced greater emphasis on fear of hypoglycaemia than
previous studies of people with longstanding type 1 DM (11).
In the second study, by Finn and colleagues, PA was
measured objectivity using an accelerometer (Actigraph) in
72 (34 males) Irish adults with type 1 DM (15). Subjectively
reported PA levels were also captured using the International
Physical Activity Questionnaire (IPAQ). The mean age (±
SD) was 41 (± 13) years and mean diabetes duration of
18 (± 12) years. This study found 23 (32%) participants
exercised to PA recommendations as measured by accelerometry,
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compared with 69 (97%) participants reporting meeting the
recommendations as per the IPAQ. This study as well
as confirming that people with type 1 DM are not very
active also underlined the inaccuracy of physical activity
questionnaires and the need to use objective measures of
activity.
It is interesting that the lower MVPA in adults with type 1
DM appears to be driven by changes in weekday activity rather
than weekend activity. During the week activity is influenced by
work patterns and the type of job a person does whereas at the
weekend people tend to have more control over their activity
patterns. It might well be that the difference we are seeing in
this study are due to a difference in the way that people travel
to work (walking vs. driving car) (16). We were unable to look at
this, as occupation was not recorded. Alternatively, people newly
diagnosed with type 1 DM may have had restrictions placed on
them by their work due to their diagnosis that may have reduced
their levels of activity. This is not something that came up in our
interviews with newly diagnosed people with type 1 DM (12) but
is something that people on occasions have mentioned to us in
clinic. Studies are needed to confirm whether this does happen
and if so how often. People with type 1 DM often have to plan
their exercise as they may have to make a change to their insulin
dose at the meal prior to exercise or eat before exercise. This
may mean that they tend to focus on exercise at the weekend
rather than during the week when they have more time to plan
for exercise. People with type 1 DM can have problems with low
or high blood glucose for 24 h after exercise. Because they do
not want to have these problems on a working day, they might
decide to do their exercise at the end of the week and at the
weekend.
More time spent being sedentary is associated with poorer
metabolic health. In a systematic review of 29 observational
studies, accelerometer-measured total sedentary time was
detrimentally associated with both glycaemic control and lipid
profile (17). People with newly diagnosed type 2 diabetes
mellitus as well as doing less MVPA than healthy controls
spend more time being sedentary (18). Conversely, in the
present study adults newly diagnosed with type 1 DM were
not found to be more sedentary than healthy controls. If
this finding is replicated in other studies, then exploring
why this is the case might give us better insight in how
to promote higher levels of MVPA and reduce sedentary
time.
The lack of difference in sedentary time could be due to
the fact that although their worries about hypoglycaemia, and
lack of knowledge and/or confidence in managing their glucose
around exercise prevents them from doing moderate and high
intensity activities it does not stop them doing low intensity
activities. Alternatively, it could be that a reduction in sedentary
time is only seen after people have had type 1 DM for a number
of years. Brazeau and colleagues did not report sedentary time
in their study (8). In the study by Finn and colleagues time
spent in sedentary time was high, with the mean time spent
being sedentary 8.4 ± 1.6 h per day (15), but as they did not
have healthy controls it is difficult to know if this is more
than that seen in people without type 1 DM of similar age and
weight. Further studies will be needed to clarify how sedentary
people with type 1 DM are and whether this changes with
time.
In our data set, women were less active than men (data
not shown). This is in keeping with an American study
that objectively measured PA in 6,329 participants and found
men to be more active than women (19) but at odds with
objectively measured activity data from 93,015 participants in
the UK Biobank study where no difference in activity was seen
between men and women (20). In our analysis we have tried
to adjust for the fact that there were more men in the Type 1
group but we might have found a greater difference in MVPA
if our two groups had been equally matched for men and
women.
Strengths and Limitations
A major strength of this study is the use of an objective and
reliable method to assesses the physical activity levels (21).
In addition, people with type 1 DM came from the EXTOD
study (2) which recruited from multiple UK sites covering both
large teaching and district general hospitals, and participants
spanned a wide age range. However, there are limitations to
this study. Due to the fact that we only measured activity
at one time point, we are unable to comment on any causal
associations between recent diabetes diagnosis and changes in
PA. Healthy controls were recruited from only two sites both
in the South West of the UK, which may limit generalizability.
It is also likely that study participants were more interested
in exercise than those who declined, and PA may be lower
in the general population of both type 1 DM and healthy
people. The small sample size of the two groups in this study
is a further limitation of this study. Nonetheless, this study
adds to the literature suggesting that longitudinal observational
studies of PA of people with newly diagnosed type 1 DM are
warranted.
CONCLUSION
In conclusion, our results indicate that adults newly diagnosed
with type 1 DM spendmore than a quarter less time doingMVPA
over the week compared to healthy adults. This suggests that
steps need to be taken to try and improve the activity levels of
adults newly diagnosed with type 1 DM. To do this clinicians
will need to be trained in how to assess and encourage activity
and also be furnished with knowledge about how to advise
patients to manage their glucose around exercise. In addition,
people with type 1 DM will need to be provided with knowledge
and skills to safely manage their glucose around exercise. We
and others are working on programmes to help support these
changes.
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